Name

Trias Pharma Gmbh

Legal name

Trias Pharma GmbH

Website

https://trias-pharma.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical CMC Consulting

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)

akta.pro secondary industry

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Pharmaceutical CMC consulting
• Drug product development
• Softgel capsule formulation
• Regulatory CMC writing
• CMO sourcing management

Headquarters

HQ city

Winterthur

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. CMC Consulting Services: Professional consulting services for formulation and analytical development of solid dosage forms. Services include project management, regulatory strategy consulting, and technical expertise throughout drug product development from concept to submission.
2. CMO Sourcing and Management: Assistance in identifying and evaluating potential CMOs, providing comprehensive benchmarking, RFQ management, and ongoing coordination of involved parties to ensure efficient project structures and reporting.
3. CMC Documentation Services: Preparation of regulatory documentation including development reports and CTD Modules for IND/IMPD filings and final registration dossiers.
4. Troubleshooting Services: Technical support for troubleshooting soft capsules and solid dosage forms, including document review and analysis of manufacturing aspects.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Trias Pharma GmbH provides hands-on CMC (Chemistry, Manufacturing, and Controls) consulting and drug product development services for pharmaceutical clients. The firm supports solid dosage form development—including softgel capsules, tablets, and hard capsules—plus specialized expertise in modified-release systems, analytical method development, regulatory CMC writing, CMO sourcing and management, and pharmaceutical development of medicinal cannabis products. Services are delivered as project-based consulting engagements from concept through regulatory submission.

Product overview

Trias Pharma Gmbh is a pharmaceutical consulting company providing hands-on CMC (Chemistry, Manufacturing and Controls) support for drug product development. Rather than a unified software platform, the company offers a portfolio of interconnected consulting services organized around core expertise areas: Softgel Capsule Development, Tablet and Hard Capsule Development, Medicinal Cannabis Development, and Analytical Development Support. These are supplemented by standalone services including CMC Consulting, CMO Sourcing and Management, CMC Writing, and Troubleshooting Services. The company leverages over a century of combined R&D experience across its team to support clients from concept through submission.

Differentiator

Problem solved

Functional benefit

Products and services

• CMC Consulting Services Expert CMC consulting for formulation and analytical development, including patent landscape evaluations, regulatory assessments for EU and US markets, on-site supervision during campaigns, and management of third parties. Targeted at pharmaceutical companies and biotech firms needing CMC expertise.
• CMO Sourcing and Management Identification and evaluation of potential Contract Manufacturing Organizations (CMOs), comprehensive benchmarking, RFQ management, supplier selection, negotiation support, and project coordination. Targeted at pharmaceutical and biotech clients needing CMO infrastructure.
• CMC Writing Preparation of development reports and CTD Modules (e.g., 2.3 and 3) for IND/IMPD files or final dossiers for registration. Targeted at pharmaceutical companies preparing regulatory submissions.
• Troubleshooting Services Support for troubleshooting of soft capsules and solid dosage forms including thorough document review and analysis of analytical and manufacturing aspects. Targeted at pharmaceutical companies facing formulation or process issues.
• Softgel Capsule Development Independent softgel capsule expertise from concept to final product, with a portfolio of over 50 softgel projects covering formulation, process development, and regulatory aspects. Targeted at pharmaceutical and biotech companies developing softgel capsule products.
• Tablet and Hard Capsule Development In-depth knowledge of all types of formulation, processes and equipment for solid dosage forms, from standard direct compression to dry and wet agglomeration techniques and film-coatings, with over 70 projects completed. Targeted at pharmaceutical companies developing modified-release or immediate-release tablets and hard capsules.
• Medicinal Cannabis Development Introduction of pharmaceutical expertise into the medicinal cannabis field, including development of inhalation devices and soft capsules with cannabis extracts, compliant with pharmaceutical standards. Targeted at medicinal cannabis companies seeking pharmaceutical-grade product development.
• Analytical Development Support Formulation expertise applied to analytical development, covering dissolution testing, method development, and characterization of complex dosage forms including softgel capsules and modified-release tablets. Targeted at pharmaceutical companies needing analytical support for complex dosage forms.

Quantifiable outcome

• Successfully registered numerous products in EU and USA markets
• +6 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Unnamed medtech startupcoreStrategic or Co-development PartnerPartnership with a medtech startup to develop a novel thermal inhalation device for precise dosing of cannabinoids. The device incorporates a unique ceramic heating element and is on track for registration as a Class IIb medicinal product under MDR guideline 2001/83/EG. Trias Pharma's responsibilities include defining the development program, connecting with clinical and regulatory opinion leaders, and managing pharmaceutical development from sourcing to IMPD documentation.
• Unnamed partner laboratory with softgel expertisecoreTechnology or IntegrationEstablished network includes partner laboratories with specific expertise in softgel testing. For dissolution method development projects, Trias Pharma selects appropriate partner laboratories from this network to support project execution.
• German Association of the Cannabis Industry (BvCW e.v.)minorOthersDr. Armin Prasch serves as board member of the German Association of the Cannabis Industry (BvCW e.v.) and leads the working group for medicinal cannabis. This association represents the cannabis industry in Germany and provides networking and industry influence opportunities.
• German Pharmaceutical Association DPhG Expert Group on Medicinal CannabisminorOthersDr. Armin Prasch is a member of the expert group on medicinal cannabis of the German Pharmaceutical Association DPhG. This membership provides access to pharmaceutical industry expertise and regulatory guidance.

Scale indicators9 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• PharmaLex (now part of Cencora): Global pharma regulatory, development, and consulting services firm with deep CMC, formulation, and regulatory dossier capabilities serving pharma and biotech clients. Highly comparable to Trias Pharma in offering independent CMC consulting from formulation through submission, though at much larger scale.
• Diamond Pharma Services: UK-based pharma regulatory and development consultancy supporting product registration, CMC, and pharmacovigilance across EU and US markets. Comparable to Trias Pharma in serving small/mid pharma and biotech clients needing independent CMC and regulatory support.
• Voisin Consulting Life Sciences: European life sciences consultancy providing CMC, regulatory affairs, and pharmaceutical development services to pharma and biotech sponsors. Closely matches Trias Pharma's independent-consulting positioning and CMC/regulatory service mix.
• ProPharma Group: Pharmaceutical consulting and compliance firm offering regulatory affairs, CMC, quality, and pharmacovigilance services across the product lifecycle. Comparable independent-consulting model with similar buyer profile of pharma and biotech sponsors.

Broad incumbents

• Alcami Corporation: US-headquartered CDMO offering integrated development, analytical, and manufacturing services for small molecules and biologics. Overlaps with Trias Pharma in solid-dose formulation and analytical development but at much larger scale and with in-house manufacturing.
• Aenova: German-headquartered CDMO with deep solid dosage form and softgel capabilities, and the former employer of multiple Trias Pharma partners. Highly comparable in therapeutic and dosage-form expertise but operates as a contract manufacturer with embedded CMC services rather than independent consulting.
• Eurofins CDMO / Pharma Services: Global testing and pharma services network offering analytical method development, CMC support, and contract manufacturing to pharma clients. Comparable analytical development expertise, particularly around dissolution and method validation for complex dosage forms.
• Recipharm: European CDMO offering pharmaceutical development, formulation, and manufacturing services for solid and other dosage forms. Overlaps with Trias Pharma in CMC and formulation development scope, but delivers as a full CDMO rather than independent consultancy.
• Glatt Pharmaceutical Services: German pharmaceutical equipment manufacturer and CDMO offering integrated process technology, formulation development, and manufacturing for solid dosage forms. Comparable in solid-form expertise and former employer of Trias Pharma's CEO; competes on adjacent capabilities.
• Catalent: Global CDMO with leading softgel capsule capabilities (among the largest independent softgel manufacturers globally), offering formulation, analytical, and regulatory services. Most direct large-scale overlap with Trias Pharma's softgel expertise area, but operating as a manufacturer rather than independent consultant.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/trias-pharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trias Pharma Gmbh